Strober, Bruce, Kim A Papp, Mary Flack, Yihua Gu, Elizabeth HZ Thompson, and Wendell C Valdecantos. “Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s10. Accessed July 5, 2022.